Ligand Pharma (LGND) PT Raised to $167 at Oppenheimer
Tweet Send to a Friend
(Updated - August 7, 2025 2:35 PM EDT)
Oppenheimer analyst Trevor Allred raised the price target on Ligand Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Trevor Allred raised the price target on Ligand Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
